Cassandra Pardini, PharmD

The combination of intranasal azelastine plus fluticasone is more effective in reducing symptom scores in patients with allergic rhinitis.

Rates of physician recommendation, administration, and referral related to vaccination differed in adult patients depending on the type of insurance they had.

A team of investigators from both Brigham and Women’s Hospital and the Massachusetts Institute of Technology analyzed data on thousands of inactive ingredients in approved medications to further characterize them and enhance our knowledge of their safety.

The NIH has announced the initiation of a phase 1 clinical trial assessing the safety, tolerability, and efficacy of a “universal” influenza vaccine candidate, H1ssF_3928, in healthy adult patients.